Velzatinib (IDRX-42) An investigational selective KIT tyrosine kinase inhibitor in clinical development for gastrointestinal stromal tumors across key KIT mutations.
Visit productCosigns Received
Be the first Cosign
Put your name behind Velzatinib (IDRX-42).
Add it to your Products I use list and share why you use it.